4-methoxybenzoyl isocyanate | 4695-57-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-methoxybenzoyl isocyanate
• 英文别名: p-methoxybenzoyl isocyanate；p-Anisoyl-isocyanat；4-Methoxybenzoylisocyanat；4-methoxybenzoic isocyanate
• CAS: 4695-57-2
• 化学式: C₉H₇NO₃
• 分子量: 177.159
• InChiKey: WBFOBYQRRHXCMI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  55.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-methoxybenzoyl isocyanate 在 四氢吡咯 作用下， 以 乙醇 、 乙腈 为溶剂， 反应 0.25h， 生成 (E)-N-(3-benzylidene-2-oxoindolin-6-ylcarbamoyl)-4-methoxybenzamide
  参考文献：
  名称：

  Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia

  摘要：

  A series of 6-acylureido derivatives containing a 3-(pyrrol-2-ylmethylidene)indolin-2-one scaffold were synthesized as potential dual Aurora B/FLT3 inhibitors by replacing the 6-arylureido moiety in 6-arylureidoindolin-2-one-based multi-kinase inhibitors. (Z)-N-(2-(pyrrolidin-l-yl)ethyl)-5-((6-(3-(2-fluoro-4-methoxybenzoyflureido)-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (54) was identified as a dual Aurora B/FLT3 inhibitor (IC50 = 0.4 nM and 0.5 nM, respectively). Compound 54 also exhibited potent cytotoxicity with single-digit nanomolar IC50 values against the FLT3 mutant-associated human acute myeloid leukemia (AML) cell lines MV4-11 (FLT3-ITD) and MOLM-13 (FLT3-ITD). Compound 54 also specifically induced extrinsic apoptosis by inhibiting the phosphorylation of the Aurora B and FLT3 pathways in MOLM-13 cells. Compound 54 had a moderate pharmacokinetic profile. The mesylate salt of 54 efficiently inhibited tumor growth and reduced the mortality of BALB/c nude mice (subcutaneous xenograft model) that had been implanted with AML MOLM-13 cells. Compound 54 is more potent than sunitinib not only against FLT3-WT AML cells but also active against sunitinib-resistant FLT3-ITD AML cells. This study demonstrates the significance of dual Aurora B/FLT3 inhibitors for the development of potential agents to treat AML. (C) 2014 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2014.07.108
• 作为产物：
  描述：

  4-甲氧基苯甲酰胺 在 盐酸 作用下， 以 二氯甲烷 为溶剂， 生成 4-methoxybenzoyl isocyanate
  参考文献：
  名称：

  Process for the preparation of acyl isocyanates

  摘要：

  这项发明涉及一种制备酰基异氰酸酯的过程，其包括将草酰氯与羧酰胺和/或氨基甲酸酯的氢卤酸盐和硫酸盐群中选取的盐反应，然后将反应混合物加热至30度至150度之间的温度。该过程适用于在易于控制的操作条件下制备出产率优异的酰基异氰酸酯。

  公开号：

  US05386057A1

文献信息

• Convenient One-Pot Two-Step Synthesis of Symmetrical and Unsymmetrical Diacyl Ureas, Acyl Urea/Carbamate/Thiocarbamate Derivatives, and Related Compounds
  作者：Jozef Stec、Anolan Hernandez、Gregory Grooms、Abir El-Alfy

  DOI：10.1055/s-0036-1588724

  日期：——

  chemist’s toolbox. A wide range of chemicals such as amides, hydrazides, amines, alcohols, carbazate, and sulfonate were reacted with acyl isocyanates generated by the reaction of primary amides with oxalyl chloride to give symmetrical and unsymmetrical diacyl urea derivatives, acyl ureas/carbamates/thiocarbamates, and related compounds. This method provides means for convenient one-pot, two-step synthesis

  献给Richard J. Whitby教授 抽象的 使各种化学物质（例如酰胺，酰肼，胺，醇，氨基甲酸酯和磺酸盐）与由伯酰胺与草酰氯反应生成的酰基异氰酸酯反应，生成对称和不对称的二酰基脲衍生物，酰基脲/氨基甲酸酯/硫代氨基甲酸酯，及相关化合物。该方法提供了从廉价的和可商购的起始试剂方便地一锅，两步合成带有脲，氨基甲酸酯和其他官能团的化合物的方法。预期本报告中提出的结果将扩展药物化学家的工具箱。 使各种化学物质（例如酰胺，酰肼，胺，醇，氨基甲酸酯和磺酸盐）与由伯酰胺与草酰氯反应生成的酰基异氰酸酯反应，生成对称和不对称的二酰基脲衍生物，酰基脲/氨基甲酸酯/硫代氨基甲酸酯，及相关化合物。该方法提供了从廉价的和可商购的起始试剂方便地一锅，两步合成带有脲，氨基甲酸酯和其他官能团的化合物的方法。预期本报告中提出的结果将扩展药物化学家的工具箱。
• Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase
  作者：Sarah E. Winterton、Emanuela Capota、Xiaoyu Wang、Hong Chen、Prema L. Mallipeddi、Noelle S. Williams、Bruce A. Posner、Deepak Nijhawan、Joseph M. Ready

  DOI：10.1021/acs.jmedchem.8b00052

  日期：2018.6.28

  Stearoyl-CoA desaturase (SCD) catalyzes the first step in the conversion of saturated fatty acids to unsaturated fatty acids. Unsaturated fatty acids are required for membrane integrity and for cell proliferation. For these reasons, inhibitors of SCD represent potential treatments for cancer. However, systemically active SCD inhibitors result in skin toxicity, which presents an obstacle to their development

  硬脂酰辅酶A去饱和酶（SCD）催化饱和脂肪酸向不饱和脂肪酸转化的第一步。膜完整性和细胞增殖需要不饱和脂肪酸。由于这些原因，SCD抑制剂代表了潜在的癌症治疗方法。但是，具有内在活性的SCD抑制剂会导致皮肤毒性，这对它们的发展构成了障碍。我们最近描述了一系列草酸二酰胺，它们通过CYP4F11介导的代谢转化为癌症子集内的活性SCD抑制剂。在本文中，我们描述了草酸二酰胺和相关N-酰基脲的优化，以及与代谢活化和SCD抑制有关的结构-活性关系的分析。
• Scalable Synthetic Strategy for Unsymmetrical Trisubstituted <i>s</i>-Triazines
  作者：Helong Liang、Ganzhong Li、Lei Zhang、Gefei Wang、Mingyu Song、Heng Li、Bingxin Yuan

  DOI：10.1021/acs.orglett.1c01970

  日期：2021.8.6

  variety of unsymmetrical trisubstituted 1,3,5-triazines was developed. This protocol applied in situ formed acyl isocyanate from amide to react with amidine, introducing two substituents to the 1,3,5-triazinone ring with a low production cost and a simple workup procedure. The scalability of this method was demonstrated by translating a small-scale procedure to a multi-kilogram-scale synthesis. Chlorination

  开发了一种可扩展的合成策略来生产多种不对称的三取代 1,3,5-三嗪。该方案应用由酰胺原位形成的酰基异氰酸酯与脒反应，以较低的生产成本和简单的后处理程序将两个取代基引入 1,3,5-三嗪酮环。该方法的可扩展性通过将小规模程序转化为数公斤规模的合成来证明。氯化和与各种亲核试剂的进一步偶联反应可以提供带有不同官能团的不对称三取代 1,3,5-三嗪。
• Studies of Acyl and Thioacyl Isocyanates. IX. The Cycloaddition Reactions of Benzoyl and Thiobenzoyl Isocyanates with Anils
  作者：Otohiko Tsuge、Shuji Kanemasa

  DOI：10.1246/bcsj.45.2877

  日期：1972.9

  Thiobenzoyl isocyanates react with benzylidenanilines, benzylidenalkylamines and dianils to yield the corresponding mono- and bis (4+2) cycloadducts. Benzoyl isocyanates do not react with benzylidenanilines, but they are easily added to benzylidenebenzylamine to give the (4+2) cycloadducts in good yields. Cycloaddition of these isocyanates to anils is dependent upon the basicity of the nitrogen atom

  硫代苯甲酰基异氰酸酯与苄基苯胺、苄基烷基胺和二苯胺反应生成相应的单和双 (4+2) 环加合物。苯甲酰基异氰酸酯不与苄叉苯胺反应，但它们很容易加入到苄叉苄胺中，以良好的产率得到 (4+2) 环加合物。这些异氰酸酯对苯胺的环加成取决于 C=N 键的氮原子的碱性。苯甲酰异氰酸酯和硫代苯甲酰异氰酸酯都没有加到肉桂基苯胺的 C=C 键上，但它们与 C=N 键反应生成 (4+2) 环加合物。
• N-(4-Substituted-benzoyl)-N′-(β-d-glucopyranosyl)ureas as inhibitors of glycogen phosphorylase: Synthesis and evaluation by kinetic, crystallographic, and molecular modelling methods
  作者：Veronika Nagy、Nóra Felföldi、Bálint Kónya、Jean-Pierre Praly、Tibor Docsa、Pál Gergely、Evangelia D. Chrysina、Costas Tiraidis、Magda N. Kosmopoulou、Kyra-Melinda Alexacou、Maria Konstantakaki、Demetres D. Leonidas、Spyros E. Zographos、Nikos G. Oikonomakos、Stanislav Kozmon、Igor Tvaroška、László Somsák

  DOI：10.1016/j.bmc.2011.12.059

  日期：2012.3

  yl)-N′-(β-d-glucopyranosyl) ureas (substituents: Me, Ph, Cl, OH, OMe, NO2, NH2, COOH, and COOMe) were synthesised by ZnCl2 catalysed acylation of O-peracetylated β-d-glucopyranosyl urea as well as in reactions of O-peracetylated or O-unprotected glucopyranosylamines and acyl-isocyanates. O-deprotections were carried out by base or acid catalysed transesterifications where necessary. Kinetic studies

  通过ZnCl 2合成了N-（4-取代的苯甲酰基）-N '-（β- d-吡喃葡萄糖基）脲（取代基：Me，Ph，Cl，OH，OMe，NO 2，NH 2，COOH和COOMe）O-过乙酰化的β- d-吡喃葡萄糖基脲的催化酰化反应以及O-过乙酰化或O-未保护的吡喃葡萄糖胺与酰基异氰酸酯的反应。必要时，通过碱或酸催化的酯交换反应进行O-脱保护。动力学研究表明，这些化合物大多数是兔肌肉糖原磷酸化酶b（RMGP b）的低微摩尔抑制剂。最好的抑制剂是4-甲基苯甲酰基化合物（K i = 2.3μM）。的几个与RMGP的化合物的复合物的晶体分析b表明，类似物利用，与水分子一起，在β口袋亚位点中的可用空间，并诱导相比RMGP一个所述280S环路的多个扩展移b在复杂与未取代的苯甲酰脲。结果表明水分子在配体结合和基于结构的配体设计中的关键作用。进行了选定抑制剂的分子对接研究，以显示结合亲和力预测的能力。计算得分最高